Pfizer Zithromax sinusitis sNDA
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Pfizer is pursuing a sinusitis indication for its antibiotic Zithromax (azithromycin) via a March sNDA submission. Zithromax' adult indications include acute exacerbations of chronic obstructive pulmonary disease, community-acquired pneumonia, tonsillitis, uncomplicated/complicated skin/skin structure infections. The drug also is indicated for otitis media in childre